openPR Logo
Press release

U.S. Influenza Vaccines Market to Surpass US$ 8.0 Billion Threshold by 2025

01-30-2018 07:23 AM CET | Health & Medicine

Press release from: CMI - Market Research

U.S. Influenza Vaccines Market to Surpass US$ 8.0 Billion

The U.S. influenza vaccines market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B) and by Age Group (Pediatrics and Adults) was valued at US$ 1.6 billion in 2016 and is projected to exhibit a CAGR of 15.9% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The U.S. influenza vaccines market is expected to gain significant traction owing to easy availability of different vaccines, which include adjuvanted inactivated vaccines, live-attenuated vaccines, seasonal influenza vaccines, and pandemic influenza vaccines. The transition from trivalent to quadrivalent vaccine formulations due to extensive research and development, to offer better protection against flu strains is a major factor to augment growth of the U.S. influenza vaccine market over the forecast period.

Innovative technologies to augment the influenza vaccine production and reduce shortage is expected to propel the market growth

Request Sample copy of Report@ https://www.coherentmarketinsights.com/insight/request-sample/1127

Manufacturers are focusing on product development by using innovative technologies such as adopting novel recombinant and cell-based vaccine production technologies to increase their supply capacity by. For instance, Protein Science Corporation received FDA approval for Flubok Trivalent Vaccine for use in the U.S. market in 2013. Flubok is the only influenza vaccine produced using recombinant technology, which offers advantages such as timely and fast vaccine production as the technology is not dependent on egg supply for vaccine production and is safe for individuals with egg-related allergies. Also, in 2016, Seqirus received FDA approval for Flucelvax quadrivalent, indicated for people aged 4 years and above. Flucevax is a four strain, inactivated seasonal influenza vaccine, which is produced using cell culture technology at the Holly Springs Facility in the U.S. The vaccine was recommended by the World Health Organization and the Food and Drug Administration for the 2016 influenza season, in order to help protect against two influenza virus strains, which include A strains and B strains.

Increasing production capacity helps to address major problems such as vaccine shortage and inequitable access, thus minimizing the cost of vaccines. For instance, in 2015, bioCSL Limited and Novartis AG developed Seqirus Company, focused on robust vaccine production for pandemic preparedness and to contribute to the prevention and control of influenza, globally. Investments in R&D is increasing significantly in order to develop new innovative technologies for launching efficacious products to increase product diversification. For instance, GlaxoSmithKline Plc is focused on research and development for the production of innovative influenza vaccines. The company has two pipeline products for the treatment of influenza virus infections via intravenous administration—Relenza, which is currently in Phase III, and Danirixin, which is in Phase II. Moreover, constant improvements on formulation and production levels, by the key players for the development of influenza vaccines is expected to boost growth of the influenza vaccines market. According to the Health Industry Distribution Association, 2016, vaccine manufacturers produced around 174.5 million doses for the 2015–16 influenza season, representing 11.1% increase from the total number of vaccines manufactured for the 2014–15 flu season in the U.S.

Key Takeaways of the U.S. Influenza Vaccines Market:

The U.S. influenza vaccines market is expected to exhibit a CAGR of 15.9% over the forecast period, owing to rise in awareness about vaccination to reduce the substantial health burden of the disease

Among vaccine types, quadrivalent vaccine segment held the dominant position in the U.S. influenza vaccines market in 2016, owing to the higher disease coverage by the vaccine and rising production capacity owing to its efficacy by major manufacturers

Among age group, adults is expected to be the dominant segment in the U.S. influenza vaccines market, owing to rising number of adult population in the country, higher availability, and easy approval of the influenza vaccines for indication in adults

Browse 20 Market Data Tables and 15 Figures spread through 120 Pages and in-depth TOC on “U.S. Influenza Vaccines Market”- Forecast to 2025

Some of the major players operating in the U.S. influenza vaccines market are Sanofi Pasteur, Seqirus Vaccines Ltd., GlaxoSmithKline Plc., and Medimmune

To know the latest trends and insights prevalent in the U.S. Influenza Vaccines Market, click the link below: https://www.coherentmarketinsights.com/market-insight/us-influenza-vaccines-market-1127

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentnews.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Influenza Vaccines Market to Surpass US$ 8.0 Billion Threshold by 2025 here

News-ID: 921417 • Views: 235

More Releases from CMI - Market Research

Adult Vaccines Market, By Types of Vaccines (Monovalent and Multivalent) - Globa …
Vaccination is one of the most effective and safest therapy that protects from diseases and reduces the prevalence of infectious diseases. There are rare side effects associated with vaccinations. Most of the vaccines are recommended on the basis of person’s age, lifestyle, travel destinations, and health conditions such as diabetes, heart diseases, asthma, and chronic obstructive pulmonary disease (COPD). According to Centers for Disease Control and Prevention (CDC), in 2013,
Optogenetics Market, By Sensors (pH Sensors, Genetically Modified Calcium Indica …
Optogenetics is an emerging medical technique, which involves the use of light to control cells in living tissues, especially neurons to help study the characteristics of normal and abnormal brain function. Optogenetics is an emerging field of biotechnology trending among the fields of neuroscience, cardiology, ophthalmology, behavioral science, and other healthcare domains. The technique is widely used to treat neurological disorders such as depression. Depression is caused by chronic stress
X-ray Equipment Market, By Product Type (Computed Tomography, Mobile X-Ray Devic …
X-ray equipment in healthcare is mainly used for imaging of bone structures, tumors, and breast cancer during surgeries, for detecting fractures in bones and teeth, as well as detecting pneumonia. Increasing prevalence of fractures due to osteoporosis, orthopedic disorders, dental problems, and increasing cases of tumor and cancer are expected to boost demand for x-ray equipment in the near future. Rampant advancements in technology and adaptation of advanced medical systems
Sterilization Equipment and Disinfectants Market – Global Industry Insights, T …
Sterilization is process of killing all micro-organisms and pathogens to avoid contamination by means of using physical or chemical treatment. Conversely disinfection is a process to control the growth of micro-organisms and kill a define class of micro-organisms. Disinfection targets narrow spectrum bacteria leaving bacterial spores intact, while sterilization works on broad spectrum micro-organisms. Autoclave uses high pressure and steam to sterilize solid and glass instruments, and liquid mediums in

All 5 Releases


More Releases for Vaccine

Tetanus Toxoid Vaccine Market
The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. Market Highlights: Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the
Vaccine Market Demand is Increasing
U.S. Vaccine Market: Snapshot The overall vaccine industry has strengthened itself in terms of its growth rate, with a relatively higher growth rate than most other healthcare market segments. Vaccination has been an invaluable addition to better public health, and has helped millions of children, adults and animals from deadly diseases. The CDC stated in a report that diseases such as diphtheria, polio, and smallpox have been fully eliminated, while measles,
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s
Shingles Vaccine Market
The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases chicken pox. The virus can stay dormant for many years in the human body. Therefore, anyone who has had